Jessica Hyde
Psychiatric/Mental Health · Austin, TXNPI 1174112957
Payments from drug & device makers
Across 168 payments — averaging $28.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Corium, LLC$610
- Alkermes, Inc.$583
- Otsuka America Pharmaceutical, Inc.$526
- Teva Pharmaceuticals USA, Inc.$328
- Axsome Therapeutics, Inc.$292
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $1,139 |
| Corium, LLC | 18 | $610 |
| Alkermes, Inc. | 19 | $583 |
| Otsuka America Pharmaceutical, Inc. | 28 | $526 |
| Teva Pharmaceuticals USA, Inc. | 3 | $328 |
| Axsome Therapeutics, Inc. | 7 | $292 |
| Lundbeck LLC | 14 | $265 |
| Novo Nordisk | 2 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $152 |
| Sumitomo Pharma America, Inc. | 1 | $129 |
| Astellas Pharma US Inc | 1 | $125 |
| Ironshore Pharmaceuticals Inc. | 4 | $67 |
| Bausch Health US, LLC | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Johnson & Johnson(2 entities) | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Tris Pharma Inc | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Biogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,844 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 12 | $220 |
| Lamotrigine | 15 | $142 |
| Lorazepam | 27 | $47 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Austin
- Jaime Nelson DensonAustin$88K
- Camille WatsonAustin$34K
- Suzanne GranthamAustin$31K
- Lin CaiAustin$16K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.